Mettler-Toledo International (MTD) Coverage Initiated by Analysts at UBS Group

UBS Group initiated coverage on shares of Mettler-Toledo International (NYSE:MTD) in a report published on Tuesday, 99wallstreet.com reports. The firm issued a neutral rating and a $625.00 target price on the medical instruments supplier’s stock.

Other equities analysts also recently issued reports about the stock. Morgan Stanley reduced their target price on shares of Mettler-Toledo International from $568.00 to $540.00 and set an equal weight rating on the stock in a research note on Friday, July 13th. JPMorgan Chase & Co. lifted their target price on shares of Mettler-Toledo International from $550.00 to $600.00 and gave the stock a neutral rating in a research note on Friday, July 27th. Finally, Zacks Investment Research raised shares of Mettler-Toledo International from a sell rating to a hold rating in a research note on Monday, July 30th. Ten investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus target price of $621.82.

MTD opened at $558.15 on Tuesday. The stock has a market cap of $15.35 billion, a P/E ratio of 31.59, a price-to-earnings-growth ratio of 2.34 and a beta of 1.08. Mettler-Toledo International has a twelve month low of $540.24 and a twelve month high of $697.26. The company has a current ratio of 1.46, a quick ratio of 1.06 and a debt-to-equity ratio of 1.92.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, July 26th. The medical instruments supplier reported $4.65 earnings per share for the quarter, topping analysts’ consensus estimates of $4.58 by $0.07. The firm had revenue of $722.00 million for the quarter, compared to analyst estimates of $715.69 million. Mettler-Toledo International had a net margin of 13.52% and a return on equity of 90.80%. Mettler-Toledo International’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the business posted $3.92 earnings per share. Equities analysts predict that Mettler-Toledo International will post 20.15 EPS for the current year.

In other news, insider William P. Donnelly sold 500 shares of the business’s stock in a transaction that occurred on Thursday, August 16th. The shares were sold at an average price of $570.00, for a total value of $285,000.00. Following the sale, the insider now directly owns 1,500 shares of the company’s stock, valued at approximately $855,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider La Guerroniere Marc De sold 740 shares of the business’s stock in a transaction that occurred on Monday, September 10th. The shares were sold at an average price of $600.00, for a total transaction of $444,000.00. Following the completion of the sale, the insider now directly owns 740 shares in the company, valued at $444,000. The disclosure for this sale can be found here. Insiders have sold 18,358 shares of company stock worth $10,744,204 over the last ninety days. 4.80% of the stock is owned by insiders.

Several institutional investors have recently added to or reduced their stakes in the company. Boston Common Asset Management LLC grew its holdings in shares of Mettler-Toledo International by 8.9% in the second quarter. Boston Common Asset Management LLC now owns 1,194 shares of the medical instruments supplier’s stock valued at $691,000 after purchasing an additional 98 shares in the last quarter. Aureus Asset Management LLC grew its holdings in shares of Mettler-Toledo International by 15.7% in the second quarter. Aureus Asset Management LLC now owns 752 shares of the medical instruments supplier’s stock valued at $435,000 after purchasing an additional 102 shares in the last quarter. Captrust Financial Advisors grew its holdings in shares of Mettler-Toledo International by 306.7% in the second quarter. Captrust Financial Advisors now owns 183 shares of the medical instruments supplier’s stock valued at $106,000 after purchasing an additional 138 shares in the last quarter. Cubist Systematic Strategies LLC grew its holdings in shares of Mettler-Toledo International by 20.7% in the first quarter. Cubist Systematic Strategies LLC now owns 823 shares of the medical instruments supplier’s stock valued at $473,000 after purchasing an additional 141 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. grew its holdings in shares of Mettler-Toledo International by 6.0% in the second quarter. Oppenheimer Asset Management Inc. now owns 2,494 shares of the medical instruments supplier’s stock valued at $1,443,000 after purchasing an additional 141 shares in the last quarter. 92.93% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.

Featured Story: Penny Stocks

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply